Medical Properties Trust, Inc. (MPW) financial statements (2021 and earlier)

Company profile

Business Address 1000 UBRAN CENTER DRIVE
BIRMINGHAM, AL 35242
State of Incorp. DE
Fiscal Year End December 31
SIC 6798 - Real Estate Investment Trusts (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
3/31/2019
Q1
12/31/2018
Q4
9/30/2018
Q3
6/30/2018
Q2
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments1,462462452996821711147
Cash and cash equivalents1,462462452996821711147
Total current assets:1,462462452996821711147
Noncurrent Assets
Property, plant and equipment7,481   4,865  
Long-term investments and receivables927777799506520  
Long-term investments927777799506520  
Intangible assets, net (including goodwill)(557)   (353)  
Intangible assets, net (excluding goodwill)(557)   (353)  
Total noncurrent assets:7,8517777995065,033  
Other undisclosed assets5,15411,2138,8737,7302,9908,0648,810
TOTAL ASSETS:14,46712,45210,1239,2318,8448,7758,957
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Noncurrent Liabilities
Other undisclosed liabilities7,4396,4655,2004,3414,2834,2885,111
Total liabilities:7,4396,4655,2004,3414,2834,2885,111
Stockholders' equity
Stockholders' equity attributable to parent7,0285,9744,9104,8774,5474,4723,831
Common stock1000000
Treasury stock, value(1)(1)(1)(1)(1)(1)(1)
Additional paid in capital7,0085,9724,8554,8044,4434,3444,339
Accumulated other comprehensive loss(63)(90)(67)(68)(58)(51)(42)
Retained earnings (accumulated deficit)8392122141163180(465)
Stockholders' equity attributable to noncontrolling interest0131314141414
Total stockholders' equity:7,0285,9874,9244,8904,5614,4873,845
TOTAL LIABILITIES AND EQUITY:14,46712,45210,1239,2318,8448,7758,957

Income statement (P&L) ($ in millions)

12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
3/31/2019
Q1
12/31/2018
Q4
9/30/2018
Q3
6/30/2018
Q2
Revenues256225193180181197202
Net investment income    324145
Cost of revenue(79)(69)(61)(102)(53)(60)(60)
Cost of goods and services sold(34)  (102)(24)  
Gross profit:17715613278127137141
Operating expenses(72)(64)(56)(57)(55)(51)(54)
Operating income:106927621738687
Nonoperating income (expense)25(3)44265326
Other nonoperating income (expense)1(2)(0)0462
Interest and debt expense(70)(65)(52)(51)(51)(57)(58)
Income (loss) from continuing operations before equity method investments, income taxes:602527(25)2468155
Other undisclosed income from continuing operations before income taxes70655299515758
Income from continuing operations before income taxes:13190807475739114
Income tax expense (benefit)(1)1024(2)(2)
Net income:13090807679736112
Net loss attributable to noncontrolling interest(0)(0)(0)(0)(0)(0)(0)
Net income available to common stockholders, diluted:13090797678736112

Comprehensive Income ($ in millions)

12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
3/31/2019
Q1
12/31/2018
Q4
9/30/2018
Q3
6/30/2018
Q2
Net income:13090807679736112
Other undisclosed comprehensive income (loss)27(23)1(10)(8)(8)(32)
Comprehensive income:1576781677172880
Comprehensive loss, net of tax, attributable to noncontrolling interest(0)(0)(0)(0)(0)(0)(0)
Comprehensive income, net of tax, attributable to parent:1576681667172879

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: